您当前的位置:
首页 >
文章列表页 >
Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation
更新时间:2025-09-24
    • Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation

    • ZHONGGUO YAOFANG   Vol. 35, Issue 24, Pages: 3071-3075(2024)
    • DOI:10.6039/j.issn.1001-0408.2024.24.18    

      CLC: R969.3
    • Received:17 July 2024,

      Revised:2024-11-26,

      Accepted:27 November 2024,

      Published:30 December 2024

    移动端阅览

  • GAO Ling,YUAN Jing,QIN Wenjie,et al.Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation[J].ZHONGGUO YAOFANG,2024,35(24):3071-3075. DOI: 10.6039/j.issn.1001-0408.2024.24.18.

  •  
  •  

0

Views

50

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine
Pharmaceutical care of reactivating anthracycline chemotherapy in a patient with advanced breast cancer combined with thyroid cancer
Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia
Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model
Pharmaceutical care for a patient with rhino-orbito-cerebral mucormycosis

Related Author

XU Lina
FANG Yingli
WANG Xiangling
DU Pengcheng
ZHANG Guangquan
LU Qi
YAN Dan
XU Silu

Related Institution

Dept. of Oncology, Qilu Hospital of Shandong University
Dept. of Clinical Pharmacy, Dezhou Hospital, Qilu Hospital of Shandong University
Dept. of Clinical Pharmacy, Qilu Hospital of Shandong University
Dept. of Pharmacy, Xuzhou Cancer Hospital
Dept. of Pharmacy, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/the Affiliated Cancer Hospital of Nanjing Medical University
0